
BIO MEDICA LABORATORIES L (BMLL) Share Price Rises 11.33% Today
Updated: 13 Oct 2026 • 10:56 am
Posted by:

BIO MEDICA LABORATORIES L Share Price is trading at Rs 167 after rising 11.33% from the previous close, and the company now has a market capitalisation of Rs 188.63 Cr. The move places BIO MEDICA LABORATORIES L Share Price in focus in today’s Healthcare market update, even though according to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking BIO MEDICA LABORATORIES L Share Price Today, the key point is simple: the stock is rising today on a sharp intraday price rise, while the latest Univest figures point to valuation and return ratios that deserve a closer look. Investors monitoring BIO MEDICA LABORATORIES L Stock News can therefore separate the verified price action from the broader fundamental picture and sector context.
BIO MEDICA LABORATORIES L Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 167 |
| Previous Close | Rs 150 |
| Today's Move | Rs 17 (+11.33%) |
| Open | Rs 146.35 |
| High | Rs 174 |
| Low | Rs 140.5 |
| Market Capitalisation | Rs 188.63 crore |
| Market Cap Category | Micro Cap |
BIO MEDICA LABORATORIES L (BMLL) rose to Rs 167 from the previous close of Rs 150, a move of Rs 17 or 11.33%. The stock opened at Rs 146.35, reached a high of Rs 174, recorded a low of Rs 140.5.
BIO MEDICA LABORATORIES L Share Price opened at Rs 146.35, touched a high of Rs 174 and a low of Rs 140.5, and last traded at Rs 167 as of 13 October 2026 at 10:52:43 AM IST. That means BIO MEDICA LABORATORIES L Share Price is up Rs 17, or 11.33%, versus the previous close of Rs 150. The day’s range shows that the stock has already moved well above the opening level, while still trading below the intraday high. For anyone following BIO MEDICA LABORATORIES L Share Price Today, the price action is clear and verified: the stock is among the notable rising today names in healthcare, and BIO MEDICA LABORATORIES L Share Price Live is being watched for whether the current level holds. The next section moves from price action to BIO MEDICA LABORATORIES L Fundamental Analysis.
The verified numbers matter because they show a strong same-day share price gain without adding any unconfirmed story around it. BIO MEDICA LABORATORIES L Share Price moved Rs 17 higher from the previous close, and that is the core event for readers scanning BIO MEDICA LABORATORIES L Share News or BIO MEDICA LABORATORIES L Stock Gaining Today headlines. The market capitalisation of Rs 188.63 Cr also places the move in a measurable company-size context. On Univest, this is best read as a price rise first, with the rest of the article explaining how the broader financial profile fits around BIO MEDICA LABORATORIES L Share Price Today.
BIO MEDICA LABORATORIES L (BMLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 188.63 crore |
| P/E Ratio | 16.16x |
| P/B Ratio | 10.41x |
| ROE | 99.59% |
| ROCE | 64.18% |
| EPS | Rs 9.28 |
| Book Value Per Share | Rs 14.42 |
| Dividend Yield | 0% |
BIO MEDICA LABORATORIES L (BMLL) fundamental metrics show P/E 16.16x, P/B 10.41x, ROE 99.59%, ROCE 64.18%. Read together, these ratios describe the company's position rather than a recommendation.
BIO MEDICA LABORATORIES L has a market capitalisation of Rs 188.63 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.16x, P/B at 10.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 99.59% and ROCE of 64.18%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 9.28, book value per share of Rs 14.42, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 16.16x |
| Benchmark Median P/E | 31.63x |
| Benchmark Average P/E | 47.13x |
| Benchmark P/E Range | 3.21x to 676.52x |
| Company P/B Ratio | 10.41x |
| Benchmark Median P/B | 2.86x |
| Company ROE | 99.59% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 64.18% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 188.63 crore |
| Benchmark Median Market Cap | Rs 814.52 crore |
BIO MEDICA LABORATORIES L (BMLL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
BIO MEDICA LABORATORIES L (BMLL) has a P/E ratio of 16.16x, which is below the benchmark median of 31.63x, a difference of -48.91%. The P/E comparison frames valuation; it is not a signal to buy or sell.
BIO MEDICA LABORATORIES L (BMLL) has a ROE of 99.59%, which is above the benchmark median of 11.61%, a difference of +757.8%. BIO MEDICA LABORATORIES L (BMLL) has a ROCE of 64.18%, which is above the benchmark median of 13.46%, a difference of +376.82%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,21,539.16 | 34.89 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 85.12 | 14.1 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,251.42 | 81.6 | 19.83 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,231.65 | 25.18 | 4.21 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,09,796.85 | 102.34 | 19.84 | 18.31 | 18.2 |
BIO MEDICA LABORATORIES L (BMLL) has a P/E ratio of 16.16x compared with the displayed peer median of 81.6x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 99.59% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 64.18% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. BIO MEDICA LABORATORIES L (BMLL) has a market capitalisation of Rs 188.63 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching BIO MEDICA LABORATORIES L
- BIO MEDICA LABORATORIES L Share Price is up 11.33% today, with Rs 167 last traded and a high of Rs 174.
- The company’s market capitalisation is Rs 188.63 Cr, which provides a clear size context for BIO MEDICA LABORATORIES L Share Price Today.
- ROE of 99.59% and ROCE of 64.18% keep BIO MEDICA LABORATORIES L Fundamental Analysis in focus.
- P/E of 16.16 is below the same-industry median of 31.63, while P/B of 10.41 is above the industry median.
- According to latest Univest figures, BIO MEDICA LABORATORIES L Share Price has a mixed valuation setup that is worth tracking alongside Healthcare sector moves.
About BIO MEDICA LABORATORIES L
BIO MEDICA LABORATORIES L operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. BIO MEDICA LABORATORIES L Share Price therefore belongs to a business category where earnings quality, book value and sector positioning often matter as much as headline price changes. The company’s market capitalisation of Rs 188.63 Cr places it within a smaller listed profile relative to many healthcare peers, while the reported ratios suggest a company with strong returns on capital. For investors reading BIO MEDICA LABORATORIES L Company News or BIO MEDICA LABORATORIES L Stock News, the key is to connect the business profile with the valuation and return metrics rather than treat the day’s price rise in isolation.
In practical terms, BIO MEDICA LABORATORIES L Share Price is being tracked because the stock has combined a sharp same-day gain with high ROE and ROCE, a moderate P/E and a richer P/B. That combination makes the company relevant in Healthcare Stock Analysis, especially when compared with much larger listed pharmaceutical names. Univest presents BIO MEDICA LABORATORIES L Share Price Today within both price and fundamentals so readers can place the move in context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is BIO MEDICA LABORATORIES L Share Price rising today?
Ans. BIO MEDICA LABORATORIES L Share Price is rising today because it is up 11.33% to Rs 167 from the previous close of Rs 150. Univest data confirms the move itself, though no company-specific trigger has been identified.
What is BIO MEDICA LABORATORIES L Share Price today?
Ans. BIO MEDICA LABORATORIES L Share Price is Rs 167 as of 13 October 2026 at 10:52:43 AM IST. The stock is trading above its previous close of Rs 150 and has already touched Rs 174 intraday.
What is the day change in BIO MEDICA LABORATORIES L Share Price?
Ans. BIO MEDICA LABORATORIES L Share Price is up Rs 17, which equals 11.33% for the day. The move follows an opening level of Rs 146.35 and sits within an intraday range between Rs 140.5 and Rs 174.
What is BIO MEDICA LABORATORIES L market capitalisation?
Ans. BIO MEDICA LABORATORIES L has a market capitalisation of Rs 188.63 Cr. In the same-industry benchmark set, the median market capitalisation is Rs 814.52 Cr, so the company sits below the industry centre.
How does BIO MEDICA LABORATORIES L look on valuation?
Ans. BIO MEDICA LABORATORIES L Share Price is linked to a P/E of 16.16 and a P/B of 10.41. That P/E is below the same-industry median of 31.63, while the P/B is above the industry median of 2.86.
What do ROE and ROCE show for BIO MEDICA LABORATORIES L?
Ans. BIO MEDICA LABORATORIES L reports ROE of 99.59% and ROCE of 64.18%. Both are far above the industry medians of 11.61% and 13.46%, which makes the return profile stand out in healthcare.
What are the EPS and book value for BIO MEDICA LABORATORIES L?
Ans. BIO MEDICA LABORATORIES L reports EPS of Rs 9.28 and book value of Rs 14.42. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Does BIO MEDICA LABORATORIES L pay a dividend?
Ans. BIO MEDICA LABORATORIES L has a dividend yield of 0. That means the current appeal in BIO MEDICA LABORATORIES L Share Price is not coming from a stated dividend return, but from price action and financial ratios.
Track BIO MEDICA LABORATORIES L Share Price on Univest
Use BIO MEDICA LABORATORIES L (BMLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track BIO MEDICA LABORATORIES L Share Price on Univest for live updates, fundamental ratios, 52-week levels, market capitalisation and broader market insights. The same page also helps readers follow BIO MEDICA LABORATORIES L Share Price Today alongside sector benchmarks, peer comparison and company-level financial ratios. For users scanning BIO MEDICA LABORATORIES L Latest News, Univest keeps the price rise, valuation context and Healthcare sector backdrop together in one place.
Recent Articles

Chennai Petroleum Q2 Results 2026: Navratna PSU Declares Rs 25 Dividend, Profit Jumps 212%, Check Record Date
22 October 2026

PC Jeweller Share Price Defies Market Gloom and Rises 90% in 2026: Can It Hit Rs 27 After Rs 20?
22 October 2026

KEI Industries Share Price Down 15% in One Month: Jefferies India Sees 45% Upside After Q2 Results
22 October 2026

Yes Bank Share Price Tumbles Over 20% in Two Weeks Amid AT-1 Bond Shock: Is More Downside Ahead?
22 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Chennai Petroleum Q2 Results 2026: Navratna PSU Declares Rs 25 Dividend, Profit Jumps 212%, Check Record Date
PC Jeweller Share Price Defies Market Gloom and Rises 90% in 2026: Can It Hit Rs 27 After Rs 20?
KEI Industries Share Price Down 15% in One Month: Jefferies India Sees 45% Upside After Q2 Results
Yes Bank Share Price Tumbles Over 20% in Two Weeks Amid AT-1 Bond Shock: Is More Downside Ahead?
Reliance Industries Share Price: Monarch Sees 20% Upside in 3-4 Months, Reveals Buy Range and Targets
Popular this week
Cement Stocks: Nuvama Stays Neutral as Rising Costs Cloud Outlook, JK Cement Top Pick

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





